Dasatinib monohydrate is a hydrate form of dasatinib, a tyrosine kinase inhibitor used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It contains dasatinib (anhydrous) and one molecule of water of crystallization.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 863127-77-9
Dasatinib
active pharmaceutical ingredient
N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(4-nitrosopiperazin-1-yl)pyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
Nitrosamine reference standard for impurity testing
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-4-oxidopiperazin-4-ium-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
Active pharmaceutical ingredient metabolite
Dasatinib Impurity 47
Dasatinib impurity reference standard
L-tyrosyl-D-alanyl-L-alpha-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-argininamide
active pharmaceutical ingredient
Cefodizime sodium
active pharmaceutical ingredient
Medetomidine
veterinary sedative anesthetic drug substance
Medetomidine hydrochloride
active pharmaceutical ingredient
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;hydrate
XHXFZZNHDVTMLI-UHFFFAOYSA-N
CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO.O